GlassScriptPhysician profile
Damodhar Suresh
NPI 1356348346
$17,484.98
in general payments reported to CMS, 2019-2025
35 companies · $2,365 in 2025
The $2,365 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,622 · 2020: $1,093 · 2021: $1,567 · 2022: $5,813 · 2023: $1,763 · 2024: $2,261 · 2025: $2,365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,080 · Travel and Lodging: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,079.82 |
| Travel and Lodging | $309.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $4,799.85 | 2019-2025 | |
| Abbott Laboratories | $1,691.57 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Coroflow, Mitraclip |
| Astrazeneca Pharmaceuticals LP | $1,585.94 | 2019-2025 | Farxiga, Andexxa, Wainua |
| Amgen INC. | $1,494.00 | 2019-2025 | Repatha, Repatha |
| Medtronic Vascular, INC. | $1,296.57 | 2019 | |
| Abiomed | $973.19 | 2021-2025 | Impella |
| Janssen Pharmaceuticals, INC | $881.64 | 2019-2023 | Xarelto |
| Medtronic, INC. | $618.81 | 2022-2024 | Corevalve Evolut R |
| Boehringer Ingelheim Pharmaceuticals, INC. | $553.75 | 2019-2025 | Jardiance |
| Pfizer INC. | $386.93 | 2019-2025 | |
| Boston Scientific Corporation | $371.22 | 2019-2024 | Bodyguardian, Watchman Access System |
| Amarin Pharma, INC. | $319.99 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $279.66 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $211.49 | 2019-2025 | Camzyos, Eliquis |
| Inari Medical, INC. | $198.11 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $193.37 | 2024 | Pascal |
| Merck Sharp & Dohme LLC | $188.65 | 2021-2025 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $170.47 | 2019-2025 | Lifevest |
| Heartflow, INC. | $166.74 | 2025 | |
| Penumbra, INC. | $152.07 | 2025 | Penumbra System |
| Regeneron Healthcare Solutions, INC. | $141.11 | 2019-2022 | |
| Novo Nordisk INC | $126.00 | 2021-2025 | Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $120.05 | 2025 | Shingrix, Arexvy, Nucala |
| Getinge USA Sales, LLC | $119.86 | 2020 | |
| Esperion Therapeutics, INC. | $115.45 | 2020-2025 | Nexletol |
| Ge Healthcare | $80.36 | 2023 | |
| Chiesi USA, INC. | $54.42 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $48.10 | 2019-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $33.56 | 2024 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $30.15 | 2021-2025 | Opsumit, Uptravi |
| Scpharmaceuticals INC. | $21.42 | 2024 | |
| Alnylam Pharmaceuticals INC. | $18.49 | 2023 | Onpattro |
| Portola Pharmaceuticals, LLC | $15.49 | 2019 | |
| Lundbeck LLC | $14.90 | 2019 | |
| Verge Medical, INC. | $11.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Damodhar Suresh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.